Results 181 to 190 of about 34,952,696 (369)

Gene signatures and immune correlations in Parkinson's disease Braak stages. [PDF]

Eur J Med Res
Sun RX, Guo Y.
europepmc   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Molecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok   +6 more
wiley   +1 more source

Artificial Intelligence Applications to Personalized Dietary Recommendations: A Systematic Review. [PDF]

Healthcare (Basel)
Wang X, Sun Z, Xue H, An R.
europepmc   +1 more source

A New Theory of Wave-Making Resistance, Based on the Exact Condition of the Surface of Ships (The Final Report)

, 1957
Takao Inui
openalex   +2 more sources

The Politics of Basing Point Legislation [PDF]

, 1950
Latham, Earl
core   +1 more source

From Eminence-Based to Error-Based to Evidence-Based Surgery [PDF]

Scandinavian Journal of Surgery, 2008
openaire   +3 more sources

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
We aggregated a cohort of 1012 mCRPC tissue samples from 769 patients and investigated the association of gene expression‐based pathways with clinical outcomes. Loss of AR signaling, high proliferation, and a glycolytic phenotype were independently prognostic for poor outcomes, and an adverse transcriptional feature score incorporating these pathways ...
Marina N. Sharifi, Eric Feng, Nicholas R. Rydzewski, Amy K. Taylor, Jamie M. Sperger, Yue Shi, Kyle T. Helzer, Matthew L. Bootsma, Viridiana Carreno, Alex H. Chang, Luke A. Nunamaker, Grace C. Blitzer, Tianfu Andy Shang, Aishwarya Subramanian, Anders Bjartell, Andreas Josefsson, Pernilla Wikström, Emily Feng, Manish Kohli, Rendong Yang, Scott M. Dehm, Eric J. Small, Rahul Aggarwal, David A. Quigley, Joshua M. Lang, Shuang G. Zhao, Martin Sjöström   +26 more
wiley   +1 more source

Optimal Methylammounium Chloride Additive for High-Performance Perovskite Solar Cells. [PDF]

Nanomaterials (Basel)
Cao Q, Liu H, Xing J, Li B, Liu C, Xie F, Zhang X, Zhao W.   +7 more
europepmc   +1 more source

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

Molecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam, Megan E. Roche, Zhao Lin, Diana Whitaker‐Menezes, Victor Diaz‐Barros, Eurico Serrano, Maria Paula Martinez Cantarin, Nancy J. Philp, Atrayee Basu Mallick, Ubaldo Martinez‐Outschoorn   +9 more
wiley   +1 more source

Haemato-Urological Profile and Asymptomatic Urinary Tract Infection in Ghanaian Steady-State Sickle Cell Disease Patients: A Case-Control Study. [PDF]

Health Sci Rep
Twumasi S, Ansah RO, Essien-Baidoo S, Basing LAW, Debrah AY, Anto EO, Ayirebi AA, Asiamah-Broni R, Attivor W, Ameyaw ET, Manu GA, Afriyie E, Gyampomah TK, Opoku JN, Amoafo PK, Owusu SK, Akwai V, Talmang M, Mensah A, Kusi-Amponsah I, Opoku A, Boateng LA.   +21 more
europepmc   +1 more source